Rehabilitation Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Rehabilitation Medicine Key Laboratory of Sichuan Province, Chengdu, Sichuan, People's Republic of China.
BMC Musculoskelet Disord. 2023 May 12;24(1):376. doi: 10.1186/s12891-023-06418-6.
BACKGROUND: Myofascial pain syndrome (MPS) is a common musculoskeletal pain and dysfunction, which is characterised by myofascial trigger points. Therapeutic physical modalities, as potentially effective treatment options, are commonly used in the clinical setting for the patients with MPS. OBJECTIVE: This systematic review aimed to evaluate the safety and effectiveness of therapeutic physical modalities in the treatment of MPS, investigate its therapeutic mechanisms and provide a scientific evidence-based decision. METHODS: According to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, the PubMed, Cochrane Central Library, Embase, and CINAHL databases were searched for randomized controlled clinical studies published from database inception to October 30, 2022. A total of 25 articles met the study inclusion criteria. Data were extracted from these studies and a qualitative analysis was performed. RESULTS: Transcutaneous electrical nerve stimulation therapy, extracorporeal shock wave therapy, laser therapy, and other therapeutic physical modalities have been demonstrated to improve the pain symptoms, joint mobility, psychological state, and quality of life in the patients with MPS and no side effects have been reported. The curative effect of therapeutic physical modalities was found to be possibly associated with increased blood perfusion and oxygen supply in ischaemic tissues, reduced hyperalgesia in the peripheral and central nerves, and decreased involuntary muscle contractions. CONCLUSION: The systematic review has shown that therapeutic physical modalities could provide a safe and effective therapeutic option for MPS. However, the consensus is currently lacking regarding the optimal treatment paradigm, therapeutic parameters, and mutual combination of therapeutic physical modalities. The clinical trials with robust quality are required to further promote the evidence-based application of therapeutic physical modalities for MPS.
背景:肌筋膜疼痛综合征(MPS)是一种常见的肌肉骨骼疼痛和功能障碍,其特征为肌筋膜触发点。治疗性物理疗法作为潜在有效的治疗选择,在临床实践中常用于 MPS 患者。
目的:本系统评价旨在评估治疗性物理疗法治疗 MPS 的安全性和有效性,探讨其治疗机制,并提供科学的循证决策依据。
方法:根据系统评价和荟萃分析的首选报告项目,检索 PubMed、Cochrane 中央图书馆、Embase 和 CINAHL 数据库,检索时间为数据库建立至 2022 年 10 月 30 日,纳入了治疗性物理疗法治疗 MPS 的随机对照临床试验研究。共 25 篇文章符合研究纳入标准。从这些研究中提取数据并进行定性分析。
结果:经皮神经电刺激疗法、体外冲击波疗法、激光疗法和其他治疗性物理疗法已被证明可改善 MPS 患者的疼痛症状、关节活动度、心理状态和生活质量,且未报告不良反应。治疗性物理疗法的疗效可能与缺血组织的血液灌注和氧供应增加、外周和中枢神经的痛觉过敏降低以及非自愿性肌肉收缩减少有关。
结论:系统评价表明,治疗性物理疗法可为 MPS 提供一种安全有效的治疗选择。然而,目前对于最佳治疗方案、治疗参数以及治疗性物理疗法的相互组合,尚未达成共识。需要高质量的临床试验来进一步促进治疗性物理疗法在 MPS 中的循证应用。
J Manipulative Physiol Ther. 2009-1
Nurse Pract. 2023-11-1
Cochrane Database Syst Rev. 2014-7-25
FP Essent. 2023-10
Phys Med Rehabil Clin N Am. 2014-5
Cochrane Database Syst Rev. 2012-4-18
Int J Environ Res Public Health. 2021-8-19